MST1 and bacterial infectious disease: Thus, the regulatory role of MST1/2 in inflammatory diseases suggests that drugs that target MST1/2 should be developed to assist antibiotics in the treatment of macrophage-related inflammatory diseases, especially drug-resistant bacterial infections.